InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Zaremba Rabourn Amy. Insider active across 2 companies, notably Ocuphire Pharma, Inc.. In total, 10 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €20k. Activity tracked since 10 January 2023. The latest transaction was disclosed on 23 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Zaremba Rabourn Amy is a declarant linked to Ocuphire Pharma, Inc. and Opus Genetics, Inc., where she is SVP of Finance. The total number of filings is 5, and, across the sampled recent filings, the period runs from 2023-01-12 to 2025-03-17, with buy and sell amounts of 0 and 0, and the modal transaction nature is Attribution.